The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making ...

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. | In the letters sent ...

A bipartisan bill at the state capitol in Denver is targeting compounded versions of popular weight loss drugs like Ozempic, Wegovy, and Zepbound, known as GLP-1s.

The FDA has issued 30 warning letters to telehealth companies over misleading claims about compounded GLP-1 drugs. Regulators ...

The FDA’s effort to crack down on compounded versions of popular GLP-1 weight-loss drugs has sparked backlash from patients ...

Add Yahoo as a preferred source to see more of our stories on Google. Wegovy and other injectable weight-loss medications have soared in popularity in the past two years. Supply issues and spotty ...

Part of "a new era of enforcement," says FDA chief ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded ...

Make sure the clinician knows what other medications you’re taking, and set up a real follow-up plan to adjust these medications and your GLP-1 dose, she added. Also, seek ongoing guidance on diet and ...

The Cost of Weight Loss Drugs With and Without Insurance Key takeaways: Weight loss drugs can cost $200 to $2,000 monthly, depending on the medication. The ...

The FDA has issued 30 warning letters to telehealth companies for making false or misleading claims about compounded GLP-1 products on their websites. The letters cite violations including claims ...